Humana (HUM) Q2 Revenue Rises 10%

Humana (NYSE:HUM), one of the largest U.S. health insurers with a major focus on Medicare Advantage and integrated healthcare services, reported its second quarter 2025 results on July 30, 2025. The most notable headline was an adjusted earnings per share (EPS) of $6.27, and revenue of $32.4 billion, both topping Wall Street estimates of $5.92 (Non-GAAP EPS) and $31.9 billion (GAAP revenue), respectively. Despite exceeding expectations, adjusted EPS fell from $6.96 in the prior year period, while GAAP revenue rose from $29.54 billion in Q2 2024, showing robust top-line growth year over year but ongoing earnings pressure. The company raised its adjusted EPS guidance and revenue targets, reflecting management’s confidence in the company’s core strategy even as challenges remain in margin performance and Medicare Advantage membership trends. Source: Analyst estimates for the quarter provided by FactSet. Humana is a major health insurer known for its concentration in Medicare Advantage—a type of health insurance plan for seniors and certain disabled individuals, provided through contracts with the U.S. government. In recent years, it has prioritized government contracts, with a particular emphasis on Medicare Advantage, Medicaid, and related services, which accounted for 85% of premiums and services revenue in FY2024.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool